Multiple myeloma in remission
Clinical trials for Multiple myeloma in remission explained in plain language.
Never miss a new study
Get alerted when new Multiple myeloma in remission trials appear
Sign up with your email to follow new studies for Multiple myeloma in remission, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new immune cell therapy outsmart resistant blood cancers?
Cure Not yet recruitingThis Phase 2 trial is testing an experimental therapy called LMY-920, which uses a patient's own immune cells (T cells) engineered to recognize and attack cancer cells through a protein called BAFF. The study aims to see if this treatment can shrink tumors or eliminate signs of c…
Matched conditions: MULTIPLE MYELOMA IN REMISSION
Phase 2 • Sponsor: Luminary Therapeutics • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
Off-the-Shelf cell therapy takes on multiple myeloma
Disease control Not yet recruitingThis early-stage trial is testing a new type of cell therapy called universal CAR-T cells for people with multiple myeloma that has not been cured by standard treatments. The therapy uses donor cells modified to target myeloma cells, aiming to be a ready-made option. The study wi…
Matched conditions: MULTIPLE MYELOMA IN REMISSION
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC